Ocio EM, Nadeem O, Schjesvold F, Gay F, Touzeau C, Dimopoulos MA, Richardson PG, Mateos MV (2022) Melflufen for the treatment of multiple myeloma Expert Rev Clin Pharmacol, 1-12 (in press) DOI 10.1080/17512433.2022.2075847, PubMed 35723075 Stokke C, Nørgaard JN, Feiring Phillips H, Sherwani A, Nuruddin S, Connelly J, Schjesvold F, Revheim ME (2022) Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients Mol Imaging Biol (in press) DOI 10.1007/s11307-022-01734-0, PubMed 35501622 Schjesvold FH, Bakker NA, Sonneveld P (2022) Melflufen in multiple myeloma: the conclusion matters - Authors' reply Lancet Haematol, 9 (4), e244-e245 DOI 10.1016/S2352-3026(22)00071-0, PubMed 35358436 More publications